Keystone Financial Group (Kentucky)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$348K Sell
9,066
-28
-0.3% -$1.08K 0.03% 286
2025
Q1
$352K Sell
9,094
-288
-3% -$11.2K 0.04% 262
2024
Q4
$317K Sell
9,382
-137
-1% -$4.63K 0.03% 285
2024
Q3
$389K Buy
9,519
+482
+5% +$19.7K 0.05% 236
2024
Q2
$348K Sell
9,037
-194
-2% -$7.47K 0.12% 112
2024
Q1
$396K Buy
9,231
+43
+0.5% +$1.84K 0.06% 210
2023
Q4
$341K Sell
9,188
-2,021
-18% -$74.9K 0.06% 197
2023
Q3
$406K Buy
11,209
+1,608
+17% +$58.3K 0.07% 178
2023
Q2
$342K Buy
+9,601
New +$342K 0.06% 198
2022
Q4
$350K Buy
9,971
+466
+5% +$16.4K 0.07% 185
2022
Q3
$280K Buy
9,505
+973
+11% +$28.7K 0.06% 211
2022
Q2
$464K Sell
8,532
-997
-10% -$54.2K 0.09% 157
2022
Q1
$519K Sell
9,529
-9
-0.1% -$490 0.09% 153
2021
Q4
$526K Sell
9,538
-21
-0.2% -$1.16K 0.09% 160
2021
Q3
$457K Buy
9,559
+19
+0.2% +$908 0.08% 172
2021
Q2
$475K Buy
9,540
+326
+4% +$16.2K 0.09% 162
2021
Q1
$411K Buy
9,214
+1,998
+28% +$89.1K 0.08% 173
2020
Q4
$332K Buy
7,216
+210
+3% +$9.66K 0.07% 184
2020
Q3
$330K Sell
7,006
-420
-6% -$19.8K 0.08% 169
2020
Q2
$379K Sell
7,426
-23
-0.3% -$1.17K 0.1% 149
2020
Q1
$353K Buy
7,449
+1,103
+17% +$52.3K 0.12% 136
2019
Q4
$373K Buy
6,346
+8
+0.1% +$470 0.1% 153
2019
Q3
$338K Buy
6,338
+1,269
+25% +$67.7K 0.1% 159
2019
Q2
$254K Sell
5,069
-216
-4% -$10.8K 0.08% 186
2019
Q1
$276K Buy
+5,285
New +$276K 0.1% 168
2018
Q4
Sell
-4,738
Closed -$237K 187
2018
Q3
$237K Buy
4,738
+4
+0.1% +$200 0.1% 169
2018
Q2
$237K Buy
4,734
+3
+0.1% +$150 0.13% 142
2018
Q1
$230K Buy
4,731
+261
+6% +$12.7K 0.13% 135
2017
Q4
$209K Buy
+4,470
New +$209K 0.13% 120